跳至主要内容
临床试验/NCT01018043
NCT01018043已完成不适用

Thai Cancer Anemia Survey in Chulalongkorn Hospital

Janssen-Cilag Ltd.,Thailand0 个研究点目标入组 264 人开始时间: 2006年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
264
主要终点
Number of patients that have anemia during cancer therapy

研究概览

简要总结

The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.

详细描述

Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemoglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with cancer

排除标准

  • 未提供

结局指标

主要结局

Number of patients that have anemia during cancer therapy

时间窗: 6 months

次要结局

  • Characteristic of each patients example treatment duration,type and chemotherapy using, grade of anemia(6 months)

研究者

发起方
Janssen-Cilag Ltd.,Thailand
申办方类型
Industry
责任方
Sponsor

相似试验